Oramed Pharmaceuticals Inc.
2 Elza Street
Jerusalem
93706
Tel: 011-972-54-7909058
Fax: 011-972-2-6792336
Website: http://www.oramedpharma.com/
Email: info@oramedpharma.com
321 articles about Oramed Pharmaceuticals Inc.
-
Oramed Pharmaceuticals Inc. Successfully Completes Phase 1A Trials
8/14/2007
-
Oramed Pharmaceuticals Inc. Completes $2 million in Financing
8/6/2007
-
Oramed Pharmaceuticals Inc. Signs Agreement With Encorium Group, Inc. To Commence Investigational New Drug Application
6/19/2007
-
Oramed Pharmaceuticals Inc. Signs Agreement with Encorium Group to Commence Investigational New Drug Application
6/19/2007
-
Exclusive Interview with Oramed Pharmaceuticals Inc. CEO, Nadav Kidron
6/6/2007
-
Oramed Pharmaceuticals Inc. Begins Phase 1 Human Clinical Trials
5/8/2007
-
Oramed Pharmaceuticals Inc. Expands Product Line With the Addition of Two New Provisional Patents in the Intellectual Property Portfolio
5/1/2007
-
Exclusive Interview With Oramed Pharmaceuticals Inc. CEO, Nadav Kidron
4/18/2007
-
Oramed Pharmaceuticals Inc. Begins Additions to an Advisory Board
4/10/2007
-
Oramed Pharmaceuticals Inc. Announces Maiden Year Progress Report
3/14/2007
-
Oramed Pharmaceuticals Inc. Announces The Completion Of Its World Renowned Scientific Board
2/22/2007
-
Oramed Pharmaceuticals Inc. Adds Another Accomplished Member To Its Scientific Board
2/21/2007
-
Oramed Pharmaceuticals Inc. Announces The Expansion Of Its Scientific Board With A Prominent American Figure In Diabetes Research
1/31/2007
-
Oramed Pharmaceuticals Inc. Further Enhances World Renowned Scientific Board Of Directors
1/16/2007
-
Oramed Pharmaceuticals Inc. Adds To Its Scientific Advisory Board
1/9/2007
-
Oramed Pharmaceuticals Inc. Discusses Benefits Of Oral Insulin Capsule Versus Insulin Inhaler
12/14/2006
-
Oramed Pharmaceuticals Inc. Signs Manufacturing Agreement For Oral Insulin Pill
11/2/2006
-
Oramed Pharmaceuticals Inc. Technology Patented With WIPO
9/13/2006
-
Oramed Pharmaceuticals Inc. Obtains Dual Listing On Frankfurt Stock Exchange
8/2/2006
-
Oramed Pharmaceuticals Inc. Receives MOH And IRB Approval To Begin Phase 1 Human Trials For Oral Insulin
7/11/2006